The global amyloidosis treatment market is on a trajectory of significant expansion, driven by heightened disease awareness, ...

Dec 18 (Reuters) - Japan's Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its experimental pill for a type of skin disease, developed using artificial intelligence, succeeded in two ...

Takeda (TAK) on Thursday announced that two pivotal late-stage trials for its oral tyrosine kinase inhibitor zasocitinib succeeded against plaque psoriasis, paving the way for the once-daily pill to ...

Please provide your email address to receive an email when new articles are posted on . Qdenga offered protection against all four dengue serotypes for 7 years, Takeda said. The vaccine is not ...

Takeda Pharmaceutical Co.’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

Takeda Pharmaceutical is bolstering its pipeline in a big way, committing $1.2 billion for rights to two late-stage Innovent Biologics cancer drugs and securing an exclusive option to license an early ...

Office: Takeda rare drug manufacturing facility. (Photo c/o Takeda Pharmaceuticals) Tokyo-based Takeda Pharmaceuticals Co. this month completed a $170 million expansion and renovation project on its ...

The Japanese company Takeda Pharmaceutical is one of the biggest employers in the Conejo Valley biotechnology sector. In Thousand Oaks, Takeda produces treatments for ultra-rare diseases, including a ...

Oct 1 (Reuters) - Takeda Pharmaceutical (4502.T), opens new tab said on Wednesday it will stop its cell therapy initiatives and seek a partner to advance its research and clinic-ready programs in this ...

Takeda's new building exterior is nearly finished with terra cotta panels that range from orange to blue. It was designed by CBT Architects. Gary Higgins To continue ...

There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...